Objectives To assess the added value of intravenous gadolinium injection to magnetic resonance imaging (MRI) -based diagnosis of abnormally invasive placenta (AIP) and to examine this in relation to the radiologist's experience.
Objectives To assess the added value of intravenous gadolinium injection to magnetic resonance imaging (MRI) -based diagnosis of abnormally invasive placenta (AIP) and to examine this in relation to the radiologist's experience.
Design Retrospective study.
Setting Between March 2009 and October 2012, 31 pregnant women who had previous caesarean delivery together with a placenta praevia and suspected placenta accreta on ultrasound in the third trimester of pregnancy.
Population All were offered MRI examination, and made aware of the limited (but so far reassuring) data regarding fetal safety of gadolinium. Twenty pregnant women agreed to undergo prenatal MRI (1.5 T), with and without gadolinium injection.
Methods Two sets of MRI examinations without and with gadolinium were reviewed independently 2 months apart by two senior and two junior radiologists; all were blinded to the outcome (known in all cases). Histopathological findings and clinical signs of AIP were considered as the defining criteria of diagnosis.
Main outcome measure accuracy of MRI with and without gadolinium was assessed.
Results Eight of the 20 women had confirmed abnormal placental invasion. The overall performance of both sets of readers in detecting AIP increased with gadolinium-sensitivity and specificity of 75.0% (42.0-100%) and 47.9% (19.9-75 .9%) increasing to 87.5% (57.1-100%) and 60.4% (33.9-86.9%), respectively (P = 0.04). The added value of gadolinium remained irrespective of radiologist's experience, although senior radiologists performed better overall (sensitivity and specificity of 87.5% and 62.5% versus 62.5% and 33.3%, respectively, increasing with injection to 93.8% and 70.8% versus 81.3% and 50%, respectively; P < 10 À4 ).
Introduction
Abnormally invasive placenta (AIP) is the abnormal morbid adherence of placental tissue to the myometrium, including placenta accreta, placenta increta and placenta percreta. 1,2 Prenatal detection is important because it has been shown to reduce maternal morbidity by allowing anticipation of perioperative complications. [3] [4] [5] Although placenta praevia 6 is far more common (1/250 pregnancies) than AIP (1/5000 pregnancies), 7 the prevalence of AIP is rising because of the growing number of pregnant women with previous terminations or caesarean deliveries; and because of advancing maternal age. 8, 9 The combination of placenta praevia and previous uterine surgery is a major risk factor for AIP. 10, 11 The management of women at risk is based not only on clinical evaluation, but also on imaging-especially during the third trimester of pregnancy. 7 Doppler ultrasonography and magnetic resonance imaging (MRI) are the two main diagnostic modalities. Ultrasound is the preferred modality for routine examination, but fetal MRI is emerging as relevant when AIP is suspected by ultrasound. 12 Although recent studies [13] [14] [15] [16] suggest similarly good performance for both modalities (ultrasound: sensitivity 91% and specificity 97%; MRI: sensitivity 92.9%, specificity 93.5%), data for determining the optimal imaging protocol are sparse. In addition, as ultrasound and MRI are often performed as complementary imaging modalities, the findings of one modality can bias the determination of another. Although ultrasound is often cited to be very operator dependent, MRI diagnosis also requires considerable expertise, based on a controversial semiology that remains difficult to master. 17 Some studies suggest that gadolinium injection could improve the ability to accurately diagnose the condition by MRI, by producing better contrast between the placenta and the myometrium. [18] [19] [20] [21] Nevertheless, the use of contrast agents, including gadolinium, remains controversial during pregnancy. [22] [23] [24] An extensive literature review could not identify any fetal effect following intrauterine exposure. 22 Although gadolinium crosses the placenta into the fetal circulation, to be excreted by the fetal kidneys into the amniotic fluid, 25, 26 a recent study in a nonhuman primate model demonstrated that minimal amounts of gadolinium are found in fetal tissue and amniotic fluid, compared with the dose injected into the mother. 26 As the added value of gadolinium injection for the diagnosis of AIP has not yet been demonstrated, the primary objective of this study was to assess whether contrast injection improves the diagnostic accuracy of MRI for AIP in women at risk. The secondary objective was to assess the influence of radiologists' experience with this rare pathology.
Material and methods

Patients
Between March 2009 and October 2012, pregnant women who had at least one previous cesarean delivery together with a placenta praevia and for whom placenta accreta was suspected (but uncertain) on ultrasound in the third trimester of pregnancy were offered an MRI examination with gadolinium used as a contrast agent.
These women were examined with a 1.5-T MRI unit (Avanto Siemens Healthcare, Erlangen, Germany, or Signa GE Healthcare, Milwaukee, WI, USA) in two referral centres (Cochin Port Royal and Necker Hospitals) that used the same MRI protocols, shown in Table 1 . The same senior radiologist was in charge of both centres (AEM). All women received information about the MRI examination, including the potential benefits and harms of gadolinium during pregnancy. All were made aware of the lack of data concerning the long-term follow up of fetuses but were informed that scientific committees allowed injection on a case-by-case basis. Institutional review board approval was obtained for this study (no. 2015/08). Before injection, sagittal, axial and coronal steady-state free precession and Single Shot Fast Spin Echo T2-weighted sequences were performed, followed by a dynamic T1-weighted dynamic volumetric examination. Contrastenhanced T1-weighted sequences then visualised the entire area of the placenta. Gadolinium chelate (Dotarem ® ; Guerbet, Aulnay-sous-Bois, France) was administered at a dose of 0.2 ml/kg of body weight with a power injector (Medrad, Maastricht, the Netherlands) at a rate of 2 ml/ second. Images were obtained sequentially at 10-to 14-second intervals for 2 minutes, beginning simultaneously with the gadolinium bolus injection (see Table S1 ). Women were asked to breathe normally during the dynamic contrast-enhanced acquisition. The overall acquisition time for the entire examination was about 20 minutes. All women were managed and followed up prospectively from the MRI examination onwards as part of our routine prenatal care for women with both a previous caesarean and placenta praevia. The final diagnosis was based on delivery data. As previously reported, 20 AIP was diagnosed if any one of the following four clinical or histological criteria was met: 20 1 Manual removal of the placenta partially or totally impossible and no cleavage plane between all or part of the placenta and uterus 2 Prenatal diagnosis of placenta accreta, confirmed by the failure of gentle attempts to remove it during the third stage of labour. When conservative treatment was chosen, placenta was left in situ 3 Evidence of gross placental invasion at the time of surgery 4 Histological confirmation of accreta on a hysterectomy specimen. Images and medical files were retrieved retrospectively for this study.
Image analysis
All MRI sets were anonymised, mixed and reviewed retrospectively and independently by two senior radiologists with more than 5 years of practical experience in fetal and placental MRI and more than 100 examinations/year (S1 and S2) and by two junior radiologists with <2 years of practical experience in fetal MRI (J1 and J2). This protocol produced four different combinations of reviews: junior/senior and with/without gadolinium injection. All readers were blinded to information provided by ultrasound and the final outcome, and the senior radiologist (AEM) who performed the first MRI examination was not involved in the review process.
Readers first reviewed a set of images from all MRI examinations with morphological sequences only. Two months later, each one of them reviewed a second set of images from the same MRI examinations, including the same morphological sequences as well as the gadolinium contrast sequences. The second set was mixed in a different order than the first set to avoid any memory contamination. Similarly, the decision to review a first set with no injection sequences was a methodological decision made to prevent potential bias that could have been introduced by interpreting morphological sequences after having seen the injected sequences.
All MRI sets were interpreted by considering seven predefined features reported in the literature 8 to be relevant in predicting AIP (Figure 1 ), compared with a normal placenta MRI (see Figure S1 ). Those features, based on morphological data, were: heterogeneous intraplacental signal intensity on T2-weighted images, focal interruption of the myometrial borders with exophytic placental tissue throughout the myometrium, dark placental bands on T2-weighted sequences, abnormal uterine bulging, visibility of the entire hypointense T2-weighted interface between the myometrium and the placenta, placental invasion of adjacent organs (suspected in case of irregularity or tenting of the bladder wall), and good contrast between the myometrium and placenta. 5, 9, 27, 28 All reviewers specifically assessed whether each one of these features was present or absent and also made an overall judgement on whether the placenta was abnormally invasive or normal.
Statistical analysis
Sensitivity and specificity were calculated for each criterion and compared for each review combination. The mean sensitivity and specificity for both junior and senior readers under each condition (MRI without or with and without injection) was obtained by mixed-effects generalised linear modelling. These models used a random patient effect, as well as separate random reader effects for each indicator (sensitivity and specificity) and condition, to allow additional testing for differences between reader categories and conditions and for interactions between them.
STATA II FOR WINDOWS (StataCorp LP; College Station, TX, USA), STATISTICA (StatSoft, Tulsa, OK, USA) and R Software (R Foundation for Statistical Computing, Vienna, Austria) were used for all statistical analyses. All tests were two-tailed and differences with P-values of < 0.05 were considered statistically significant.
Results
Patient population
During the study period, 31 women fulfilled the inclusion criteria of our study; gadolinium-MRI was not provided in 11 women (35%), either because they declined MRI, declined gadolinium injection or gave birth before MRI could be performed. Our study therefore included 20 pregnant women (mean AE SD age: 34.7 AE 2.4 years), all at risk for AIP based on a history of caesarean delivery and presence of placenta praevia. Clinical, surgical, and pathology data were available for all women and are shown in the Supplementary material (Table S1 ). AIP was diagnosed in eight women (seven accreta and one percreta): three were histologically confirmed (hysterectomy-criterion 4), and five were confirmed as placenta accreta because of the failure of gentle attempts to remove the placenta during the third stage of labour (criterion 2) and treated with conservative management. 29 The other 12 women were finally considered not to have AIP, but only placenta praevia: ten because of an uneventful delivery with normal delivery of the placenta, and two after histological proof of a normal placenta after hysterectomy for per-partum haemorrhage unrelated to placental invasion.
Statistics
The sensitivity and specificity of each of the MRI features were reported, for the junior and senior readers and according to the presence of gadolinium (see Table S2 ). For the junior radiologists, injection improved the sensitivity of both the visibility of the placental-myometrial interface (25% versus 68.5%) and the appropriate contrast between the myometrium and placenta (43.7% versus 87.5%). On the other hand, it led to a reduction in the sensitivity of the senior doctors' assessment of placental invasion of adjacent organs (62.5% versus 18.7%).
The overall sensitivity and specificity for detecting placental invasion with and without gadolinium are reported in Table 2 . The use of gadolinium was associated with an improvement in overall performance for both junior and senior readers (Figure 2 ): the sensitivity was 75.0% (42.0-100%) without contrast injection and 87.5% (57.1-100%) (A) (B) Figure 1 . Placenta accreta in a woman at 34 weeks of gestation. (A) Sagittal steady-state free precession: the border between the myometrium and the placenta is not correctly identified. (B) Sagittal T1-weighted three-dimensional fat-saturated sequence with gadolinium injection: the border between the placenta and the myometrium is clearly identified (arrowhead) and the myometrial border shows focal interruptions, with exophytic abnormal placental tissue throughout the myometrium (two white arrows), that emphasises the accreta area. *The overall performance of both sets of readers in detecting AIP increased when gadolinium was used (sensitivity and specificity of 75.0% (42.0-100%) and 47.9% (19.9-75.9%) increasing to 87.5% (57.1-100%) and 60.4% (33.9-86.9%), respectively (P = 0.04). **The added value of gadolinium remained irrespective of radiologist's experience, although senior radiologists performed better overall (sensitivity and specificity of 87.5% and 62.5% versus 62.5% and 33.3% respectively increasing with injection to 93.8% and 70.8% versus 81.3% and 50%, respectively; P < 10
À4
).
with it; specificity was 47.9% (19.9-75.9%) and 60.4% (33.9-86.9%), respectively (P = 0.04). The added value of gadolinium did not differ between the senior (improvements in sensitivity and specificity of + 6.3% and + 8.3%, respectively) and junior (+ 18.7% and + 16.7%) radiologists (P = 0.43). Nonetheless, the performance of the senior radiologists was better, both with injection (sensitivity 93.8%; specificity 70.8%) and without injection (sensitivity 87.5%; specificity 62.5%) than that of the junior radiologists (sensitivity 81.3%; specificity 50.0% and sensitivity 62.5%; specificity 33.3%, respectively; P < 10 À4 ).
Discussion
Main findings
This study demonstrates that both contrast injection and radiologists' experience increase the ability to diagnose AIP by MRI significantly and independently. These findings are likely to influence practice because the prevalence of this potentially fatal condition continues to increase 10, 11 and because prenatal identification of women with any form of placenta accreta and planning their delivery have been shown to decrease maternal mortality and morbidity. [1] [2] [3] 5, 23, 24 In addition to prenatal diagnosis and elective delivery at 34-35 weeks of gestation, 3, 5 improved prognosis has been related to delivery in a tertiary-care hospital with a multidisciplinary care team 23 and to the performance of a caesarean hysterectomy with no attempt to remove the placenta. 4 However, a falsepositive diagnosis also increases maternal morbidity because unnecessarily invasive procedures expose women to inherent complications. 7 
Strengths and limitations
The added value of MRI to ultrasound in the diagnosis of AIP is still debated. 30 In our study, both sensitivity and specificity of MRI, without knowledge of ultrasound conclusion, with or without injection, remained far from excellent even in the hands of experienced radiologists. This is consistent with recent data. 30 However, we report for the first time that in cases of prenatal suspicion of AIP after ultrasound, gadolinium injection significantly improves the performance of MRI for both less-experienced and expert radiologists. This is therefore likely to influence the overall assessment of the added value of MRI. Although many experts believe that sonographic imaging is more accurate than MRI 31 for the diagnosis of this condition, this may not remain true when gadolinium is used. Contrast injection provides better delineation of the outer placental surface proximal to the myometrium, which in turn helps to distinguish between heterogeneous signals arising from the placenta and those caused by maternal blood vessels and therefore enhances the specificity of MRI. 30 Our results also show that injection increases the contrast within the interface between the placenta and the myometrium (Figure 1 ). Contrast injection does not appear to improve the individual performance of the other diagnostic features, mainly those defined by Lax on T2 morphological sequences (including but not limited to heterogeneous placental signals and dark placental bands). 6 Although the experience of the radiologist remains an independent factor in the diagnostic accuracy of MRI, gadolinium injection can make up in part for the operator's lack of experience. The most reliable MRI features of AIP are dark placental bands (hypointense on T2 weighting), infiltration of the pelvic organs and focal interruptions of the myometrial border. 17 The latter is the most experience-dependent feature and our study shows that its identification by the junior doctors is likely to be improved by contrast injection (62.5% without injection and 81.2% with). Compared with control placental beds, those with placenta increta show vessels that are both larger and smaller and less uniformly distributed throughout the placenta bed. 32 The MRI T2-weighted half-Fourier acquisition single-shot turbo spin-echo (HASTE) shows irregular dark bands related to abnormal fibrin deposition and dilated tortuous signal voids indicative of abnormal vascular lacunae. 33 Neovascularisation observed in placenta accreta is also the basis for the added value of Doppler ultrasound imaging. 34 The main strength of this study is its methodological approach using radiologists from different departments and geographical areas. They were blinded to the prevalence of placental invasion in the sample, ultrasound findings and to the pregnancy outcome. Their readings reproduced daily practice with sets of MRI interpreted without and with gadolinium, with knowledge of the clinical context. A delay of 2 months was imposed between the two study phases, to avoid any memory contamination between the two readings. Moreover, the order of the second MRI reading set was changed, to reduce the possibility of recognition between the two sets.
Gadolinium crosses the placenta and can diffuse in the amniotic fluid, and its use during pregnancy is therefore controversial. 22, 35 The transplacental passage of gadolinium-based contrast agents is a significant safety concern in the routine use of gadolinium-MRI in suspected AIP. 36 Nonetheless, 18 academic centres in Europe, Asia and the USA responded to a survey about the use of gadolinium during pregnancy and reported no fetal malformations or adverse effects. 37 The European Society of Radiology has issued guidelines 22 concluding that gadolinium is safe during pregnancy because the dosage used for MRI diagnostic purposes is not expected to cross the placenta; moreover, it is not thought that it would be toxic to the fetus if it did. These guidelines also state that, given that gadolinium is distributed mainly in extracellular water and rapidly eliminated by the kidneys, it would, in the unlikely event that it reached the fetus, be rapidly eliminated into the amniotic fluid and probably transferred back to the mother. 25 Overall, we consider it justified to use gadolinium contrast media if the expected benefit is likely to outweigh the potential risk, after providing pregnant women with clear information, specifically its increased diagnostic accuracy for AIP and consequently potentially improved maternal outcome. In view of the limitations of these data, however, gadolinium injection should be reserved for MRI in women whose diagnosis of AIP remains uncertain on morphological sequences only, and further studies are needed before recommending the use of MRI with gadolinium on a routine basis.
The potential limitations of our study are its relatively small sample size, with only eight AIP and 12 non-AIP diagnosed in two referral centres, as well as the limited number of radiologists used to read the images. These results should be confirmed by larger, more homogeneous trials. 38 Nevertheless, despite the small size of the sample, our preliminary results illustrate a way to improve the accuracy of the diagnosis, regardless of the operator's experience. To our knowledge, no data about such an improvement have been reported. Another limitation of this study is that definitive diagnosis of placenta accreta was achieved with conservative management for five women (5/8) . This approach makes it very difficult to be sure about the true positives and negatives, but is an inherent limitation in studies of AIP.
Interpretation
The improvement in diagnostic accuracy with gadolinium injection reflects on gadolinium-based vascular enhancement that improves the distinction between placental tissue and a thin myometrium and highlights the vascular heterogeneity of AIP. Nonetheless, alternative enhanced MRI methods, such as fusion-imaging with colour Doppler, and advanced techniques, 39 such as BOLD 40 and ASL, might also be developed to avoid extrinsic injection and could prove useful in picking up abnormal vascular patterns.
Conclusion
Gadolinium injection increased the diagnostic accuracy of AIP by MRI both for experienced and inexperienced radiologists. The MRI features, however, remain subjective, and dependent upon the radiologists' experience. New imaging features and automated analysis modalities are required to provide a more reliable diagnosis of AIP.
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When the accuracy for the detection of AIP using US and MRI was compared, similar results were obtained. Nevertheless, the performance of both imaging techniques for the detection of AIP is suboptimal. False-negative cases of AIP may represent an increase in maternal morbimortality, as some crucial interventions that are indicated in suspected AIP may not be performed. The indication of a scheduled caesarean delivery in a tertiary referral centre with a multidisciplinary team significantly improves outcomes. False-positives for AIP represent unnecessary maternal-fetal morbidity. For this reason, there is an real need to improve the diagnostic imaging accuracy for AIP.
In this study, the authors tested the hypothesis that gadolinium contrast could improve the diagnostic performance of MRI for AIP. One of the main strengths of the study is its novelty, as gadolinium is not frequently used during pregnancy owing to safety concerns. Uncertainty surrounds the risk of possible fetal effects because gadolinium contrast is a water-soluble agent and can cross the placenta into the fetal circulation and amniotic fluid. The main concern is that the duration of fetal exposure is unknown because it can be swallowed from amniotic fluid re-entering the fetal circulation, which could potentially increase the risk of fetal harm. Nevertheless, studies have shown how no adverse perinatal or neonatal outcomes were detected in cases that received this agent during the first trimester ( The results provided in this study show how the use of gadolinium significantly increased the diagnostic sensitivity and specificity (+12.5% for both), suggesting that the use of this contrast agent could constitute a new reliable way of improving the detection rate of AIP in patients at risk. This should be considered a great achievement that may be helpful particularly in cases of inconclusive MRI scans and that may potentially reduce the morbimortality associated with AIP. Nevertheless, we should keep in mind that technical advances and upcoming studies may show how other MRI contrast agents that do not cross the placenta, or the use of additional MRI sequences, could also help to increase the accuracy of the detection of AIP (Siauve et al. Am J Obstet Gynecol 2015;213:S103) from an expectedly safer and non-invasive perspective.
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